aspirin

Plants in a forest respond to stress by producing a chemical form of aspirin, scientists have discovered. The finding opens up new avenues of research into the behavior of plants, and it has the potential to give farmers an early warning signal about crops that are failing.

Researchers have uncovered the mechanism that may explain aspirin's ability to prevent arterial plaque buildup and atherosclerosis.

Researchers report the development of a new group of aspirin-like substances that may be safer and as effective as conventional aspirin for fighting heart disease, the leading cause of death in the developed world.

Physicians have known for years that daily low-doses of aspirin, or acetylsalicylic acid, reduce the risk of developing heart attacks and stroke in some people.

However, prolonged use of aspirin can damage the stomach lining, causing bleeding and ulcers that can be life-threatening.

A safer form of aspirin is needed, researchers say.

Stroke patients who use ibuprofen for arthritis pain or other conditions while taking aspirin to reduce the risk of a second stroke undermine aspirin's ability to act as an anti-platelet agent, researchers have shown.

Stroke patients who use ibuprofen for arthritis pain or other conditions while taking aspirin to reduce the risk of a second stroke undermine aspirin's ability to act as an anti-platelet agent, researchers at the University at Buffalo have shown.

Experts who reviewed studies on NSAIDs and breast cancer have concluded that there is sufficient evidence to suggest that these popular non-prescription drugs could, if used correctly, play an important role in preventing and treating breast cancer.

They suggest that they could reduce breast cancer by up to 20 percent. The 27-year review covers 21 studies of 37,000 women.

But further research is needed to see if the risks outweigh the benefits.

Experts who reviewed studies on NSAIDs and breast cancer have concluded that there is sufficient evidence to suggest that these popular non-prescription drugs could, if used correctly, play an important role in preventing and treating breast cancer.

They suggest that they could reduce breast cancer by up to 20 percent. But further research is needed to see if the risks outweigh the benefits.

The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to new, highly targeted therapies against the disease.

The finding also helps explain how daily use of medicines such as aspirin might help keep these breast tumors at bay.

Up to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an antiplatelet response from aspirin, the effect thought to produce the protective effect, researchers at the University at Buffalo have shown.

Up to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an antiplatelet response from aspirin, the effect thought to produce the protective effect, researchers at the University at Buffalo have shown.